ANDA 83484, held by Ivax Sub Teva Pharms. Butabarbital Sodium.
As of Nov 16, 2026, ANDA 83484 (Sodium Butabarbital), held by Ivax Sub Teva Pharms, was first approved by FDA on Sep 25, 1973, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 25, 1973 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Sodium Butabarbital15MG ยท tablet;oral | Butabarbital Sodium | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters